←Back to Expert Scholars
Translational Medicine / 转化医学GVHD, Biomarkers
James Ferrara
MD
🏢Icahn School of Medicine at Mount Sinai🌐USA
Professor and Director, Hematologic Malignancies Translational Research
140
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
James Ferrara co-leads the MAGIC consortium and has defined the ST2-REG3a biomarker signature for acute GVHD prognosis and risk stratification. His laboratory established the cytokine storm concept of GVHD. He has mentored many transplant translational scientists.
Share:
🧪Research Fields 研究领域
acute GVHD
GVHD biomarkers
ST2
MAGIC consortium
transplant research
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 James Ferrara 的研究动态
Follow James Ferrara's research updates
留下邮箱，当我们发布与 James Ferrara（Icahn School of Medicine at Mount Sinai）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment